Stockreport

bioAffinity Technologies Set for Continued Expansion in 2025

bioAffinity Technologies, Inc.  (BIAF) 
PDF Noninvasive CyPath® Lung test for lung cancer contributes to growing revenues SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a bi [Read more]